Carlyle Group Inc. Exicure, Inc. Transaction History
Carlyle Group Inc.
- $837 Million
- Q2 2024
A detailed history of Carlyle Group Inc. transactions in Exicure, Inc. stock. As of the latest transaction made, Carlyle Group Inc. holds 281,636 shares of XCUR stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
281,636
Previous 281,636
-0.0%
Holding current value
$1.07 Million
Previous $168,000
46.43%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding XCUR
# of Institutions
17Shares Held
766KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$1.07 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$215,3370.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA46KShares$175,2670.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$152,7540.0% of portfolio
-
Ubs Group Ag17.3KShares$65,9540.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $18.9M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...